726
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13

, , , , , & show all
Pages 2441-2446 | Received 22 Feb 2016, Accepted 27 Mar 2016, Published online: 24 May 2016

References

  • Dagan R, Greenberg D, Jacobs MR, Phillips BL. Pneumococcal infections. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th Edition. Eds: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL. Saunders Elsevier. Philadelphia PA. 2009. 1288-342
  • Kyaw MH, Rose CE, Fry AM, Singleton JA, Moore Z, Zell ER, Whitney CG. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005; 192:377-86; PMID:15995950; http://dx.doi.org/10.1086/431521
  • Herffernan RT, Barrett NL, Gallagher M, Hadler JL, Harrison LH, Reingold AL, Khoshnood K, Holford TR, Schuchat A. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005; 191:2038-45; PMID:15897989; http://dx.doi.org/10.1086/430356
  • Jordano Q, Falco V, Almirante B, Planes A, del Valle O, Ribera E, Len O, Pigrau C, Pahissa A. Invasive pneumococcal disease in patients infected with HIV: still a threat in the the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:1623-8; PMID:15156452; http://dx.doi.org/10.1086/420933
  • CDC. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46:1-24
  • Bogaert D, de Groot R, Hermans PW. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis 2004; 4: 144-54; PMID:14998500; http://dx.doi.org/10.1016/S1473-3099(04)00938-7
  • Janoff EN, O'Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, Douglas JM, Jr. Streptococcus pneumoniae: colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993; 167:9-56; http://dx.doi.org/10.1093/infdis/167.1.49
  • Rodriguez-Barradas MC, Tharapel RA, Groover JE, Giron KP, Lacke CE, Houston ED, Hamill RJ, Steinhoff MC, Musher DM. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis 1997; 175:590-7; PMID:9041330; http://dx.doi.org/10.1093/infdis/175.3.590
  • Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: A cross-sectional study. PLoS Med 2011; 8:1-9; http://dx.doi.org/10.1371/journal.pmed.1001017
  • Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, Gove J, Bruden DL, Rudolph K, Parkinson A, et al. Impact of conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis 2004; 190:2031-8; PMID:15529269; http://dx.doi.org/10.1086/425422
  • Onwubiko C, Swiatlo E, McDaniel LS. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era. J Clin Microbiol 2008; 3632-5
  • Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumonia: An explanation of trends in invasive pneumococcal disease. J Infect Dis 2006; 193:1487-94; PMID:16652275; http://dx.doi.org/10.1086/503805
  • Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346-54; PMID:17922399; http://dx.doi.org/10.1086/521626
  • Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW, et al. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 2011; 53:137-43; PMID:21690620; http://dx.doi.org/10.1093/cid/cir326
  • Burgos J, Falcó V, Borrego A, Sordé R, Larrosa MN, Martinez X, Planes AM, Sánchez A, Palomar M, Rello J, et al. Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect 2013; 19:385-91; PMID:22583156; http://dx.doi.org/10.1111/j.1469-0691.2012.03895.x
  • Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41; PMID:19947881; http://dx.doi.org/10.1086/648593
  • Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011. Emerg Infect Dis 2013; 19:1074-83; PMID:23763847; http://dx.doi.org/10.3201/eid1907.121830
  • CDC. Prevention of Pneumococcal Disease Among Infants and Children — Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2010; 59:1-18
  • CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2012; 61:816-9
  • Heinsbroek E, Tafatatha T, Phiri A, Ngwira B, Crampin AC, Read JM, French N. Persisting high prevalence of pneumococcal carriage among HIV-infected adults receiving antiretroviral therapy in Malawi: a cohort study. AIDS 2015; 29(14):1837-44; PMID:26218599; http://dx.doi.org/10.1097/QAD.0000000000000755
  • Harimurti K, Saldi SR, Dewiasty E, Khoeri MM, Yunihastuti E, Putri T, Tafroji W, Safari D. Nasopharyngeal carriage of Streptococcus pneumoniae in adults infected with human immunodeficiency virus in Jakarta, Indonesia. J Infect Public Health 2016; S1876-0341(16):00015-0
  • Cohen R, Varon E, Doit C, Schlemmer C, Romain O, Thollot F, Béchet S, Bonacorsi S, Levy C. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation. Vaccine 2015; 33:5118-26; PMID:26271823; http://dx.doi.org/10.1016/j.vaccine.2015.08.010
  • Dunais B, Bruno P, Touboul P, Degand N, Sakarovitch C, Fontas E, Haas H, Girard-Pipau F, Ruimy R, Pradier C. Impact of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of Streptococcus pneumoniae among children attending group daycare in Southeastern France. Pediatr Infect Dis 2015; 34:286-8; http://dx.doi.org/10.1097/INF.0000000000000559
  • Panel on opportunistic infections in HIV-infected adults and adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medical Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 5/14/13
  • Nuorti JP, Butler CJ, Farley MM, Harrison LH, McGeer A, Kolcaak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000; 342:681-9; PMID:10706897; http://dx.doi.org/10.1056/NEJM200003093421002
  • Hirschtick RE, Glassroth J, Hordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995; 333:845-51; PMID:7651475; http://dx.doi.org/10.1056/NEJM199509283331305
  • Yin Z, Rice BD, Waight P, Miller E, George R, Brown AE, Smith RD, Slack M, Delpech VC. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS 2012; 26:87-94; PMID:22008657; http://dx.doi.org/10.1097/QAD.0b013e32834dcf27
  • Davis JL, Fei M, Huang L. Respiratory infection complicating HIV infection. Curr Opin Infect Dis 2008; 21:184-90; PMID:18317044; http://dx.doi.org/10.1097/QCO.0b013e3282f54fff
  • Kohli R, Lo Y, Homel P, Flanigan TP, Gardner L, Howard AA, Rompalo AM, Moskaleva G, Schuman P, Schoenbaum EE. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis 2008; 43:90-8; http://dx.doi.org/10.1086/504871
  • Kuo CY, Hwang KP, Hsieh YC, Cheng CH, Huang FL, Shen YH, Huang YC, Chiu CH, Chen PY, Lin TY. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine 2011; 29:511-7; http://dx.doi.org/10.1016/j.vaccine.2011.05.034
  • Mameli C, Fabiano V, Bedogni G, Faccini M, Garlaschi ML, Penagini F, Dilillo D, Torresani E, Gramegna M, Zuccotti GV. A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era. Hum Vaccin Immunother 2015; 11:811-7; PMID:25751237; http://dx.doi.org/10.1080/21645515.2015.1010945
  • Kamng'ona AW, Hinds J, Bar-Zeev N, Gould KA, Chaguza C, Msefula C, Cornick JE, Kulohoma BW, Gray K, Bentley SD, et al. High multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children. BMC Infect Dis 2015; 15:234; http://dx.doi.org/10.1186/s12879-015-0980-2
  • Marsh R, Smith-Vaughan H, Hare KM, Binks M, Kong F, Warning J, Gilbert GL, Morris P, Leach AJ. The nontypeable pneumococcus: phenotypic dynamics in the era of anticapsular vaccines. J Clin Microbiol 2010; 48:831-5; PMID:20042626; http://dx.doi.org/10.1128/JCM.01701-09
  • Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P, Cheng L. Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet 2014; 46:305-9; PMID:24509479; http://dx.doi.org/10.1038/ng.2895
  • Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, Sherwood L, Zmitrovich A, Jerris R, Satola SW, et al. Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia. Pediatr Infect Dis J 2015; 34(11):1168-74; epub ahead of print
  • McElligott M, Vickers I, Meehan M, Cafferkey M, Cunney R, Humphreys H. Noninvasive pneumococcal clones associated with antimicrobial nonsusceptibility isolated from children in the era of conjugate vaccines. Antimicrob Agents Chemother 2015; 59:5761-7; PMID:26169397; http://dx.doi.org/10.1128/AAC.00990-15
  • Tam PI, Young ME. Serotype 35B pneumococcal meningitis in an infant: effect of conjugate vaccines on invasive disease and implications for practice. Clin Pediatr 2015; 55(4):377-9; pii: 0009922815586056
  • Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae. J Infect Dis 2015; 211:1144-53; http://dx.doi.org/10.1093/infdis/jiu576
  • Mendes RE, Hollingsworth RC, Costello A, Jones RN, Isturiz RE, Hewlett D, Farrell DJ. Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012. Antimicrob Agents Chemother 2015; 59:5595-601; PMID:26124173; http://dx.doi.org/10.1128/AAC.00182-15
  • Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. Antimicrob Agents Chemother 2014; 58:6484-9; PMID:25136018; http://dx.doi.org/10.1128/AAC.03344-14
  • Metcalf BJ, Gertz RE, Gladstone RA, Walker H, Sherwood LK, Jackson D, Li Z, Law C, Hawkins PA, Chochua S, et al. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect 2015; 22(1):60.e9-60.e29; PMID:26363404
  • Austrian R. The Quellung Reaction, A Neglected Microbiologic Technique Mount Sinai J Med 1976; 43:669-709
  • Farnham AC, Zimmerman CM, Papadouka V, Konty KJ, Zucker JR, Nattanmai GV, Jose S, Rosen JB. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012. JAMA Pediatr 2015; 169:646-52; PMID:25938798; http://dx.doi.org/10.1001/jamapediatrics.2015.0612

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.